Evaluation of a New Recovery-oriented Model of Psychiatric Inpatient Care
1 other identifier
observational
700
1 country
1
Brief Summary
This project will study the effects of a major reorganization of psychiatric inpatient wards. This reorganization will affect many aspects of day-to-day work, with the aim of improving the individualization of care, the integration of relatives and the participation of the patients in treatment planning. This new organization will initially involve a first pilot ward, before being extended to other wards. The aim of this project is to understand whether this new organization has positive effects on the use of coercive measures, the average length of stay, the improvement in patients' clinical condition, as well as on patient satisfaction, their perception of coercion, the wards' atmosphere on the unit and patients' personal recovery. All patients admitted to three wards of the Division of adult psychiatry of the Geneva University Hospital aged 18 and over, with a good knowledge of French and being treated for any type of diagnosis except dementia, are invited to take part in the study. They will be assessed at discharge regarding the selected outcomes. The study will last 18 months: during the first 9 months, the new model will be applied on the pilot ward, and the wo other wards will serve as comparison wards. After 9 months, the model will also be applied to these other two wards.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 29, 2024
CompletedFirst Posted
Study publicly available on registry
February 9, 2024
CompletedStudy Start
First participant enrolled
February 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2025
CompletedJuly 3, 2024
July 1, 2024
1.6 years
January 29, 2024
July 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Coercive measures
Number, type and duration of used coercive measures (seclusion or forced medication)
For each included participant at discharge from hospital, throughout the study (18 months)
Secondary Outcomes (9)
Length of stay
For each included participant at discharge from hospital, throughout the study (18 months)
Symptom burden
For each included participant at discharge from hospital, throughout the study (18 months)
Length of stay under involuntary status
For each included participant at discharge from hospital, throughout the study (18 months)
Personal recovery
For each included participant at discharge from hospital, throughout the study (18 months)
Subjective coercion 1
For each included participant at discharge from hospital, throughout the study (18 months)
- +4 more secondary outcomes
Study Arms (2)
Intervention group
All patients admitted to the ward implementing the foreseen intervention as to February 2024 (pilot phase)
Control group
All patients admitted to the two wards implementing the foreseen intervention after the initial pilot phase
Interventions
The intervention envisages major structural changes in wards, in particular the reorganization of clinical discussion and decision-making spaces, as well as the medical and nursing referral system, and the inclusion of relatives in care: * Treatment planning involving the patient, with a focus on his or her needs and resources. * Care by referral teams, present every day of the week, to ensure continuity and consistency of care. * As few decisions as possible made without the patient, and transparency in decision-making. * Emphasis on the subjective meaning of illness, beyond symptoms. * Greater visibility of care planning for patients, who will benefit from weekly agendas * Closer collaboration with relatives, through open invitations to all clinical discussions, telephone hotlines and meeting times. * Openness to the network and community care, by promoting communication and exchanges between all stakeholders, and the development of early warning tools such as the joint crisis plan.
Eligibility Criteria
All patients admitted to the three participating wards during the study period will be considered for participation. All diagnoses will be included, except for dementia. Patients who are not able to give their written consent to participation and/or with insufficient knowledge of French will be excluded from the study.
You may qualify if:
- Patients hospitalized in one of the three participating wards
You may not qualify if:
- Incapacity to give informed consent
- Insufficient knowledge of French
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Genevalead
- Fondation Privée des HUGcollaborator
- IF International Foundationcollaborator
Study Sites (1)
HUG - Hôpital de Belle-Idée
Thônex, 1226, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandre Wullschleger, MD
University Hospital, Geneva
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
January 29, 2024
First Posted
February 9, 2024
Study Start
February 15, 2024
Primary Completion
October 1, 2025
Study Completion
October 1, 2025
Last Updated
July 3, 2024
Record last verified: 2024-07